77 related articles for article (PubMed ID: 21327931)
21. Clinical update on K-Ras targeted therapy in gastrointestinal cancers.
Pant S; Hubbard J; Martinelli E; Bekaii-Saab T
Crit Rev Oncol Hematol; 2018 Oct; 130():78-91. PubMed ID: 30196915
[TBL] [Abstract][Full Text] [Related]
22. [Personalized therapy of gastrointestinal cancers--possibilities and limitations].
Wichert Gv; Adler G; Seufferlein T
Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1687-91. PubMed ID: 20721844
[TBL] [Abstract][Full Text] [Related]
23. Deciphering molecular determinants of chemotherapy in gastrointestinal malignancy using systems biology approaches.
Lin LL; Huang HC; Juan HF;
Drug Discov Today; 2014 Sep; 19(9):1402-9. PubMed ID: 24793142
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Advances in GI Malignancies--Fifth Annual Conference. 13-14 July 2007, Newport Beach, CA, USA.
Alberts SR
IDrugs; 2007 Oct; 10(10):693-5. PubMed ID: 17899484
[No Abstract] [Full Text] [Related]
25. Molecular Determinants of Statin-sensitivity in Cancer.
Fatehi Hassanabad A; Wong JVS
Am J Clin Oncol; 2020 Mar; 43(3):160-162. PubMed ID: 31842115
[No Abstract] [Full Text] [Related]
26. 2014 Gastrointestinal Cancers Symposium.
McLarnon A
Lancet Oncol; 2014 Mar; 15(3):262. PubMed ID: 24809097
[No Abstract] [Full Text] [Related]
27. Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.
Xiao Y; Liu Q; Peng N; Li Y; Qiu D; Yang T; Kang R; Usmani A; Amadasu E; Borlongan CV; Yu G
Cell Transplant; 2022; 31():9636897221075749. PubMed ID: 35168393
[TBL] [Abstract][Full Text] [Related]
28. Statin as a therapeutic agent in gastroenterological cancer.
Uemura N; Hayashi H; Baba H
World J Gastrointest Oncol; 2022 Jan; 14(1):110-123. PubMed ID: 35116106
[TBL] [Abstract][Full Text] [Related]
29. Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis.
Jeong GH; Lee KH; Kim JY; Eisenhut M; Kronbichler A; van der Vliet HJ; Shin JI; Gamerith G
J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979352
[TBL] [Abstract][Full Text] [Related]
30. Lovastatin induces apoptosis of HepG-2 cells by activating ROS-dependent mitochondrial and ER stress pathways.
Wang Y; Xie Y; Ma J; Gong R; Yan Z; Wang W; Wang Y; Xu B; Li X
Int J Clin Exp Pathol; 2017; 10(12):11480-11488. PubMed ID: 31966503
[TBL] [Abstract][Full Text] [Related]
31. Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade.
Huang SW; Chyuan IT; Shiue C; Yu MC; Hsu YF; Hsu MJ
J Cell Mol Med; 2020 Jan; 24(2):1822-1836. PubMed ID: 31821701
[TBL] [Abstract][Full Text] [Related]
32. Drug repurposing to overcome resistance to various therapies for colorectal cancer.
Fong W; To KKW
Cell Mol Life Sci; 2019 Sep; 76(17):3383-3406. PubMed ID: 31087119
[TBL] [Abstract][Full Text] [Related]
33. Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis.
Li Y; He X; Ding Y; Chen H; Sun L
Cancer Med; 2019 Jun; 8(6):3305-3313. PubMed ID: 31069997
[TBL] [Abstract][Full Text] [Related]
34. Effect of survivin downregulation by simvastatin on the growth and invasion of salivary adenoid cystic carcinoma.
Cai WY; Zhuang Y; Yan F; Li T; Song WT; Sun JH
Mol Med Rep; 2018 Aug; 18(2):1939-1946. PubMed ID: 29956779
[TBL] [Abstract][Full Text] [Related]
35. Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.
Chang CF; Tseng YC; Huang HH; Shih YL; Hsieh TY; Lin HH
Intern Emerg Med; 2018 Mar; 13(2):191-197. PubMed ID: 29235054
[TBL] [Abstract][Full Text] [Related]
36. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
Parrales A; Ranjan A; Iyer SV; Padhye S; Weir SJ; Roy A; Iwakuma T
Nat Cell Biol; 2016 Nov; 18(11):1233-1243. PubMed ID: 27775703
[TBL] [Abstract][Full Text] [Related]
37. Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade.
Yen CS; Chen JC; Chang YF; Hsu YF; Chiu PT; Shiue C; Chuang YF; Ou G; Hsu MJ
Sci Rep; 2016 Apr; 6():25082. PubMed ID: 27122225
[TBL] [Abstract][Full Text] [Related]
38. Targeting Oncogenic Mutant p53 for Cancer Therapy.
Parrales A; Iwakuma T
Front Oncol; 2015; 5():288. PubMed ID: 26732534
[TBL] [Abstract][Full Text] [Related]
39. Statin use and risk of liver cancer: an update meta-analysis.
Shi M; Zheng H; Nie B; Gong W; Cui X
BMJ Open; 2014 Sep; 4(9):e005399. PubMed ID: 25227628
[TBL] [Abstract][Full Text] [Related]
40. Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.
Burr NE; Talboys RJ; Savva S; Clark A; Phillips M; Metcalfe M; Dennison A; Robinson R; Lewis MP; Rhodes M; Rushbrook S; Hart AR
Dig Dis Sci; 2014 Jul; 59(7):1567-72. PubMed ID: 24535250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
